Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 53 for:    Orange B

Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients (B12-POCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03485404
Recruitment Status : Recruiting
First Posted : April 2, 2018
Last Update Posted : June 19, 2019
Sponsor:
Collaborators:
First Affiliated Hospital Xi'an Jiaotong University
Tang-Du Hospital
Shaanxi Provincial People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Anhui Provincial Hospital
Shanghai 10th People's Hospital
Information provided by (Responsible Party):
Lize Xiong, Xijing Hospital

Brief Summary:
This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

Condition or disease Intervention/treatment Phase
Post Operative Cognitive Dysfunction Drug: methylcobalamin Drug: Folic Acid Other: Placebo for methylcobalamin Other: Placebo for folic acid Procedure: non-cardiac surgery Behavioral: NPB test Not Applicable

Detailed Description:

Vitamin B12 has long been suggested to have neural nutrient effect and widely used in clinical settings for patients with peripheral nerve injury as well as complementary medicine for patients with CNS disorders, including cognitive dysfunction. Evidences showed that, although no significant improvement in cognitive function was observed in healthy elderly after vitamin B12 supplementation, some studies suggested that patients with pre-existing CNS disorder may benefit from Vitamin B12. Post operational cognitive dysfunction (POCD) is severe, and long-lasting complication that affects as high as 53% of patients in high risk surgeries. Age is an independent risk factor for POCD. Researches have shown that serum vitamin B12 level decrease with age, and methylcobalamin (active form of Vitamin B12) content in the frontal cortex of aged patients are lower than that of younger patients. However, there are no report on effect of preemptive supplementation of vitamin B12 on POCD incidence. Therefore, the current research is aimed to explore the preoperative methylcobalamin supplementation (500 mg, 3/day for 7 days before surgery) on incidence of POCD. Folic acid supplementation is a common companion for vitamin B12 treatment in clinical settings because they are in the same methionine cycle, increase of one may result in deficiency of another. So we added 5 mg, 1/day of folic acid with methylcobalamin in the treatment group.

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2178 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Masking Description: Central randomization. Groups are marked as A and B with no participants, care provider, investigator and outcome assessors know which group is the drug and which is the placebo. Placebo are made as tablets that mimics the color, shape and size of the drugs.
Primary Purpose: Prevention
Official Title: Effect of Preoperative Vitamin B12 on Post Operative Cognitive Dysfunction in Elderly Patients Undergoing Non-cardiac Surgery: A Multi-Center, Prospective, Randomized, Double-blinded, Controlled Clinical Trial
Actual Study Start Date : January 10, 2019
Estimated Primary Completion Date : May 20, 2020
Estimated Study Completion Date : August 20, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: VB12+FA
Patients will receive oral supplementation of 0.5mg methylcobalamin, 3/day and 5 mg folic acid, 1/day for 7 days before non-cardiac surgery.
Drug: methylcobalamin
methylcobalamin tablets, 0.5mg/tablet, 3 tablets/day.
Other Names:
  • vitamin B12
  • VB12

Drug: Folic Acid
folic acid tablets, 5mg/tablet, 1 tablet/day
Other Name: vitamin B9

Procedure: non-cardiac surgery
patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

Behavioral: NPB test
participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
  • neuropsychological battery tests
  • assessment of POCD

Placebo Comparator: Placebo
Patients with receive oral tablets of placebo for folic acid 1/d and placebo for methylcobalamin 3/d, which look exactly like the interventional drugs as oral supplementation for 7 days before non-cardiac surgery.
Other: Placebo for methylcobalamin
orange tablets that looks exactly like methylcobalamin

Other: Placebo for folic acid
yellow tablets that looks exactly like folic acid

Procedure: non-cardiac surgery
patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

Behavioral: NPB test
participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
  • neuropsychological battery tests
  • assessment of POCD

Non-surgical controls
Age and sex-matched community elderly people are included for two sessions of NPB test evaluation for calculation of POCD incidence as normal control to in Z value calculation of POCd incidence to rule out learning effect.
Behavioral: NPB test
participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
  • neuropsychological battery tests
  • assessment of POCD




Primary Outcome Measures :
  1. Incidence of POCD at discharge or 7 days after operation [ Time Frame: at discharge or at 7 days after operation if the patient is not discharged by then ]
    POCD incidence is defined as two or more test of the neuropsychological battery declined as compared to preoperative baseline.


Secondary Outcome Measures :
  1. Activity daily living score [ Time Frame: 3 months after operation ]
    Telephone interview of activity daily living score (14 items, 1-4 points per item, ranging 14-56 points with 56 being the worst-unable to complete any task of everyday living.)

  2. Serum level of vitamin B12, folic acid and homocysteine [ Time Frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1 ]
    Ten ml of venous blood will be collected from patients to test the differences of serum levels of vitamin B12, folic acid and homocysteine to show the effect of preoperative supplementation and surgery stimulation on these parameters.

  3. Serum level of cystatin C and myeloid differentiation protein 2 [ Time Frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1 ]
    Ten ml of venous blood will be collected from patients to test the differences of serum levels of cystatin C and myeloid differentiation protein 2.

  4. Length of hospital stay [ Time Frame: Date from hospital admission to hospital discharge. This length is usually around 7-14 days. It may be longer if the patient have one or more complications. The length will be documented at patient discharge, up to 100 weeks. ]
    to see if our intervention could reduce the total days of patient spent in hospital,

  5. Incidence of in hospital complications [ Time Frame: From date of hospital admission to date of hospital discharge after surgery. Usually 7-14 days, assessed up to 100 weeks. ]
    Overall rate of perioperative major complications including hemorrhage, deep vein thrombosis, cardiovascular complications, respiratory complications, acute kidney injury, infection or second operative needed, during patient's hospital stay.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 1. Age equals or over 65
  • 2. Scheduled for spinal or joint replacement surgery under general anesthesia,estimated surgery time over 2h.
  • 3. Signed written informed consent obtained
  • 4. Non-surgical Controls are age and sex - matched community elderly residents.

Exclusion Criteria:

  • 1. Disease of the central nervous system that impairs cognitive function, including all kinds of dementia, and depression
  • 2. MMSE score < 24
  • 3. Received education for less than 5 years
  • 4. Currently taking sedative or antidepressant drugs
  • 5. Has taken vitamin B12, folic acid or their derivatives (methycobalamin, cobalamin, tetrahydrofolic acid, etc.) within 6 months.
  • 6. Has accepted cardiac or neurological surgery within one year.
  • 7. Was admitted for other clinical trials within 3 month
  • 8. Patients that regularly taking drugs that affect vitamin B absorption, including colchicine, neomycin, salicylate.
  • 9. Has severe visual or auditory problems
  • 10. Alcohol or drug dependent (alcohol dependent: drank more than 100 mL of Chinese liqueur with alcohol concentration over 40% everyday for the past 3 months).
  • 11. Patients that are already admitted for this study can not be admitted the second time, no matter the cause of surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485404


Contacts
Layout table for location contacts
Contact: Lize Xiong, M.D., Ph.D. +862984771262 mzkxlz@126.com
Contact: Jiao Deng, M.D., Ph.D. +862984771262 peazi@126.com

Locations
Layout table for location information
China, Anhui
Anhui Provincial Hospital Recruiting
Hefei, Anhui, China, 230001
Contact: Juan Li, M.D., Ph.D.    +8613956005465    huamuzi1999@126.com   
China, Hebei
The Third Hospital of Hebei Medical University Not yet recruiting
Shijiazhuang, Hebei, China
Contact: Xiuli Wang    +8613313019968      
China, Henan
Henan Provincial People's Hospital Not yet recruiting
Zhengzhou, Henan, China
Contact: Jiaqiang Zhang    +8613937121360      
China, Jiangsu
Nanjing Drum Tower Hospital Not yet recruiting
Nanjing, Jiangsu, China, 210008
Contact: Zhengliang Ma, M.D., Ph.D.    +8613611586781    13611586781@163.com   
China, Shaanxi
First Affiliated Hospital of Xi'an Jiaotong University Not yet recruiting
Xi'an, Shaanxi, China, 710032
Contact: Qiang Wang, M.D., Ph.D.    +8613991236768    dr.wangqiang@139.com   
Shaanxi Provincial People's Hospital Recruiting
Xi'an, Shaanxi, China, 710032
Contact: Rui Yang, M.D., Ph.D.    +8613572135219    yangrui20008@163.com   
Tangdu Hospital Not yet recruiting
Xi'an, Shaanxi, China, 710032
Contact: Xude Sun, M.D., Ph.D.    +8613891905550    sunxude@fmmu.edu.cn   
Xijing Hospital Recruiting
Xi'an, Shaanxi, China, 710032
Contact: Lize Xiong, M.D., Ph.D.    +862984771262    mzkxlz@126.com   
Contact: Guangchao Zhao, M.D., Ph.D.    +8618691800175    peazi@126.com   
Principal Investigator: Lize Xiong, M.D., Ph.D.         
China, Shandong
Shandong Provincial Qianfoshan Hospital Not yet recruiting
Jinan, Shandong, China
Contact: Yuelan Wang, M.D.    +8615953105780      
China
Shanghai 10th People's Hospital Not yet recruiting
Shanghai, China, 200072
Contact: Yuan Shen, M.D., Ph.D.    +8618602169932    dr.yuanshen@foxmail.com   
Shanghai Changzheng Hospital Not yet recruiting
Shanghai, China
Contact: Hongbin Yuan, M.D.    +8613795229316      
Sponsors and Collaborators
Xijing Hospital
First Affiliated Hospital Xi'an Jiaotong University
Tang-Du Hospital
Shaanxi Provincial People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Anhui Provincial Hospital
Shanghai 10th People's Hospital
Investigators
Layout table for investigator information
Study Chair: Lize Xiong, M.D., Ph.D. Xijing Hospital

Layout table for additonal information
Responsible Party: Lize Xiong, Professor, Xijing Hospital
ClinicalTrials.gov Identifier: NCT03485404     History of Changes
Other Study ID Numbers: KY20172057-1
First Posted: April 2, 2018    Key Record Dates
Last Update Posted: June 19, 2019
Last Verified: June 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Lize Xiong, Xijing Hospital:
POCD
vitamin B12
folic acid

Additional relevant MeSH terms:
Layout table for MeSH terms
Vitamin B 12
Vitamin B Complex
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders
Vitamins
Folic Acid
Hydroxocobalamin
Micronutrients
Nutrients
Growth Substances
Physiological Effects of Drugs
Hematinics